GitHub projects have been targeted with malicious commits and pull requests, in an attempt to inject backdoors into these projects.
Most recently, the GitHub repository of Exo Labs, an AI and machine learning startup, was targeted in the attack, which has left many wondering about the attacker’s true intentions.
Proteins in people’s blood could be used to find and even one day prevent cancers, according to the team behind two of our latest studies.
Lung cancer is among the leading causes of cancer-related deaths globally, and one of its most prevalent and distressing symptoms is a persistent cough. It’s a startling reality that lung cancer can remain asymptomatic for far too long, with a cough being one of the first indications of its presence.
Among the myriad of symptoms attributed to lung cancer, coughing bears a significance difficult to understate. Here, we outline the basic features of a cough caused by lung cancer.
Big Tech’s AI spending continues to accelerate at a blistering pace, with the four giants well on track to spend upwards of a quarter trillion dollars predominantly towards AI infrastructure next year.
Though there have recently been concerns about the durability of this AI spending from Big Tech and others downstream, these fears have been assuaged, with management teams stepping out to highlight AI revenue streams approaching and surpassing $10 billion with demand still outpacing capacity.
Below, I take a look at the growth in AI spending from Big Tech this year and yet, as it quickly approaches the quarter-trillion mark, and next week, I’ll discuss exactly what this means for the market’s biggest beneficiary.
A team of scientists led by Northwestern Medicine investigators has created an implant capable of reversing an opioid overdose, according to findings published in Science Advances.
More than 100,000 people died from an opioid overdose in 2022, according to data collected by the Centers for Disease Control and Prevention. Synthetic opioid drugs including fentanyl have accelerated the rise in overdose deaths in the U.S. and are responsible for roughly 70 percent of all overdose deaths.
Although naloxone, sold as an over-the-counter nasal spray or injectable, can reverse an overdose, administering the medication requires a knowledgeable bystander, limiting its lifesaving potential.
I dunno what’s wrong with Facebook, but it’s AI keeps doing dumb things.
Is your cat saying “feed me!” or “I love you?” A new AI-powered app promises to demystify what your feline is saying.
People with a phobia of needles may soon experience relief with an innovative blood sampling method inspired by leeches.
I love the analogy they use here of space flight — a deeply impressive human accomplishment that has, nevertheless, primarily relied on engineering solutions because the science behind it is relatively well understood. It’s a great reminder that BCIs are not “rocket science” because, unlike rocket science, we don’t yet have the science to underpin the engineering that advances will rely on.
Yet despite this, Gordon and Seth throw a bone to engineers who can’t wait for the science to catch up. And they do this by suggesting that artificial intelligence may “soften” if not completely eliminate the science challenges facing the development of successful BCIs.
At this point it’s hard to tell how far AI-driven engineering solutions might support BCIs designed to enhance performance — and Gordon and Seth suggest that near term technologies may be “limited to controlling apps on phones or other similarly prosaic activities”. But they also acknowledge that, in spite of the considerable challenges, BCIs still hold promise for human enhancement in the future.
Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.
Mutant RAS, they found, helps to kick off a series of events involving the transport of specific nuclear proteins that lead to uncontrolled tumor growth, according to a study published November 11, 2024, in Nature Cancer.
RAS genes are the second most frequently mutated genes in cancer, and mutant RAS proteins are key drivers of some of the deadliest cancers, including nearly all pancreatic cancers, half of colorectal cancers, and one-third of lung cancers.
